Back to mobile site

Morgan Stanley Upgrades Quest Diagnostics (DGX) to Overweight

December 17, 2024 3:59 AM EST Send to a Friend
(Updated - December 17, 2024 4:27 AM EST)

Morgan Stanley analyst Erin Wright upgraded Quest Diagnostics (NYSE: DGX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login